Moderna Inc (MRNA)
125.00
-0.59
(-0.47%)
USD |
NASDAQ |
May 03, 16:00
125.43
+0.43
(+0.34%)
After-Hours: 20:00
Moderna Total Assets (Quarterly): 16.73B for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 16.73B |
December 31, 2023 | 18.43B |
September 30, 2023 | 19.45B |
June 30, 2023 | 21.88B |
March 31, 2023 | 24.12B |
December 31, 2022 | 25.86B |
September 30, 2022 | 26.06B |
June 30, 2022 | 26.04B |
March 31, 2022 | 27.61B |
December 31, 2021 | 24.67B |
September 30, 2021 | 20.92B |
June 30, 2021 | 16.15B |
Date | Value |
---|---|
March 31, 2021 | 12.69B |
December 31, 2020 | 7.337B |
September 30, 2020 | 4.651B |
June 30, 2020 | 3.486B |
March 31, 2020 | 2.068B |
December 31, 2019 | 1.589B |
September 30, 2019 | 1.591B |
June 30, 2019 | 1.685B |
March 31, 2019 | 1.806B |
December 31, 2018 | 1.962B |
September 30, 2018 | 1.489B |
December 31, 2017 | 1.084B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.589B
Minimum
Dec 2019
27.61B
Maximum
Mar 2022
15.15B
Average
17.58B
Median
Total Assets (Quarterly) Benchmarks
Merck & Co Inc | 106.68B |
Pfizer Inc | 226.50B |
Eli Lilly and Co | 63.94B |
Johnson & Johnson | 171.97B |
Novavax Inc | 1.797B |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 3.912B |
Shareholders Equity (Quarterly) | 12.82B |
Current Ratio | 4.034 |